ALMKT:EPA
Mauna Kea Technologies SA
0,094 €
arrow_upward
+1,73%(+0,0016) 1D
13 nĂ«n, 2:00:36 m.d., GMT+1 · EUR
search
TĂ« gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALMKT...
Hap
0,09 €
I lartë
0,10 €
I ulët
0,09 €
Kapitalizimi i tregut
18,80Â mln
VĂ«llimi mesatar
541,14 mijë
VĂ«llimi
52,93 mijë
Raporti çmim/fitim
0,80
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26Â mln
Numri i punonjësve
56
Hap
0,09 €
I lartë
0,10 €
I ulët
0,09 €
Kapitalizimi i tregut
18,80Â mln
VĂ«llimi mesatar
541,14 mijë
VĂ«llimi
52,93 mijë
Raporti çmim/fitim
0,80
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26Â mln
Numri i punonjësve
56
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Yahoo! Finance Canada
·
21 minuta më parë
Xenetic Biosciences Reports Third Quarter 2026 Financial Results and Highlights Strategic Business Updates
ChartMill
·
15 minuta më parë
S&P 500 Premarket Movers: Travelers, Palo Alto Networks Gain; Cisco, AMD Fall
Kitco
·
18 minuta më parë
Nasdaq futures subdued as Nvidia upheaval roils AI trade
Bloomberg.com
·
3 orë më parë
Goldman Sees S&P 500 Rising 14% on Cheap Hyperscaler Valuations
Profili
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Rreth Mauna Kea Technologies SA
Drejtori ekzekutivSacha Loiseau
Punonjësit56
Themeluar më2000
Selia-
SektoriHealth Care
IndustriaMedical device
Uebsajtimaunakeatech.com